RobertAlanNathanMD
Allergy & Immunology • Colorado Springs, COAsthma and Allergy Associates and Research Center
Dr. Nathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2709 N Tejon St
Colorado Springs, CO 80907Phone+1 719-473-0872Fax+1 719-630-3658
Education & Training
University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1978 - 1979- University of Colorado School of Medicine/National Jewish Health (Adult)Fellowship, Allergy and Immunology, 1977 - 1978
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1974 - 1977
University of Miami Leonard M. Miller School of MedicineClass of 1974
Certifications & Licensure
CO State Medical License 1977 - 2025
FL State Medical License 1975 - 2010
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification Aprima EHR, Aprima Medical Software, Inc., 2012-2013
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Publications & Presentations
PubMed
- Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study.John Oppenheimer, Huib A Kerstjens, Louis-Philippe Boulet, Nicola A Hanania, Edward Kerwin
The Journal of Allergy and Clinical Immunology. in Practice. 2024-09-01 - 109 citationsEfficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, ra...Laurie A Lee, Zelie Bailes, Neil Barnes, Louis-Philippe Boulet, Dawn Edwards
The Lancet. Respiratory Medicine. 2021-01-01 - 11 citationsA phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroidsEdward Kerwin, Steven Pascoe, Zelie Bailes, Robert A. Nathan, David I. Bernstein
Respiratory Research. 2020-06-12
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
